1. Home
  2. NEOG

NEOG

Neogen Corporation

Logo Neogen Corporation

Health Care

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.

Founded: 1981 Country:
United States
United States
Employees: 2640 City: LANSING
Market Cap: 2.7B IPO Year: 1989
Target Price: $23.50 AVG Volume (30 days): 2.0M
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.02 EPS Growth: -50.00
52 Week Low/High: $12.18 - $24.10 Next Earning Date: 04-09-2024
Revenue: $929,238,000 Revenue Growth: 28.93%
Revenue Growth (this year): 16.35% Revenue Growth (next year): 5.02%

Share on Social Networks: